Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Hair loss may increase heart disease risk.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Hair loss needs more research for better treatments.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride helps reduce heart issues and improves heart function.